Column Group L P
Director10% Owner

Column Group L P insider trades: Ngm Biopharmaceuticals (NGM) stock buys and sales

Director, Ngm Biopharmaceuticals Last trade Nov 16, 2023 135 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
125
Open-market trades
since 2014
4
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Column Group L P reports to the SEC

Open-market buys and sales

125 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 16, 2023NGM↑ Buy$16K
Nov 16, 2023NGM↑ Buy$16K
Nov 16, 2023NGM↑ Buy$16K
Jan 31, 2023NGM↑ Buy$921K
Jan 31, 2023NGM↑ Buy$921K
Jan 31, 2023NGM↑ Buy$921K
Jan 23, 2023NGM↑ Buy$49K
Jan 23, 2023NGM↑ Buy$49K
Jan 23, 2023NGM↑ Buy$49K
Jan 20, 2023NGM↑ Buy$191K
Jan 20, 2023NGM↑ Buy$191K
Jan 20, 2023NGM↑ Buy$191K
Jan 12, 2023NGM↑ Buy$27K
Jan 12, 2023NGM↑ Buy$27K
Jan 12, 2023NGM↑ Buy$27K
Jan 11, 2023NGM↑ Buy$1.5M
Jan 11, 2023NGM↑ Buy$1.5M
Jan 11, 2023NGM↑ Buy$1.5M
Dec 12, 2022NGM↑ Buy$1K
Dec 12, 2022NGM↑ Buy$1K
Dec 12, 2022NGM↑ Buy$1K
Nov 22, 2022NGM↑ Buy$202K
Nov 22, 2022NGM↑ Buy$202K
Nov 22, 2022NGM↑ Buy$202K
Nov 4, 2022NGM↑ Buy$684K
Nov 4, 2022NGM↑ Buy$684K
Nov 4, 2022NGM↑ Buy$684K
Oct 27, 2022NGM↑ Buy$374K
Oct 27, 2022NGM↑ Buy$374K
Oct 27, 2022NGM↑ Buy$374K
Oct 26, 2022NGM↑ Buy$595K
Oct 26, 2022NGM↑ Buy$595K
Oct 26, 2022NGM↑ Buy$595K
Jun 9, 2022NGM↑ Buy$13.3M
Jun 9, 2022NGM↑ Buy$13.3M
Jun 2, 2022NGM↑ Buy$446K
Jun 2, 2022NGM↑ Buy$446K
Jun 1, 2022NGM↑ Buy$2.1M
Jun 1, 2022NGM↑ Buy$2.1M
May 27, 2022NGM↑ Buy$309K
May 27, 2022NGM↑ Buy$309K
May 25, 2022NGM↑ Buy$820K
May 25, 2022NGM↑ Buy$820K
May 20, 2022NGM↑ Buy$530K
May 20, 2022NGM↑ Buy$530K
May 18, 2022NGM↑ Buy$2.0M
May 18, 2022NGM↑ Buy$2.0M
May 16, 2022NGM↑ Buy$428K
May 16, 2022NGM↑ Buy$428K
May 12, 2022NGM↑ Buy$1.9M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Column Group L P's insider trades

Column Group L P is a director at Ngm Biopharmaceuticals (NGM). Since Jul 29, 2014, it has reported 123 open-market purchases worth $184.5M and 2 sales worth $739K on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include option exercises (5 filings), conversions (5 filings), other transactions (4 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NGM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.